Ascendis Pharma A (ASND) EBIT Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) EBIT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 79.65% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 29.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.83% |
| Dec 31, 2025 | 27.58% |
| Sep 30, 2025 | 27.82% |
| Jun 30, 2025 | 26.57% |
| Mar 31, 2025 | 8.63% |
| Dec 31, 2024 | 1,370.51% |
| Sep 30, 2024 | 2.41% |
| Jun 30, 2024 | -0.43% |
| Mar 31, 2024 | 29.19% |
| Dec 31, 2023 | 29.84% |
| Sep 30, 2023 | -16.69% |
| Jun 30, 2023 | -18.85% |
| Mar 31, 2023 | -24.04% |
| Dec 31, 2022 | -27.95% |
| Sep 30, 2022 | -34.33% |
| Jun 30, 2022 | -37.73% |
| Mar 31, 2022 | -30.96% |
| Dec 31, 2021 | -46.55% |
| Sep 30, 2021 | -36.92% |
| Jun 30, 2021 | -37.72% |